Verition Fund Management
BMY icon

Verition Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Verition Fund Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Buy
49,000
+36,600
+295% +$2.13M 0.02% 810
2025
Q4 		$669K Sell
12,400
-38,700
-76% -$1.86M ﹤0.01% 2448
2025
Q3 		$2.3M Sell
51,100
-13,200
-21% -$616K 0.01% 1850
2025
Q2 		$2.98M Buy
64,300
+28,000
+77% +$1.37M 0.01% 1599
2025
Q1 		$2.21M Buy
36,300
+29,200
+411% +$1.7M 0.01% 1498
2024
Q4 		$402K Sell
7,100
-500
-7% -$27.9K ﹤0.01% 2607
2024
Q3 		$393K Hold
7,600
– – ﹤0.01% 2468
2024
Q2 		$316K Hold
7,600
– – ﹤0.01% 2319
2024
Q1 		$412K Buy
+7,600
New +$387K ﹤0.01% 2115
2023
Q1 		– Sell
-5,800
Closed -$417K – 2166
2022
Q4 		$417K Sell
5,800
-8,900
-61% -$671K 0.01% 1336
2022
Q3 		$1.04M Buy
+14,700
New +$1.07M 0.01% 1360
2022
Q2 		– Sell
-24,100
Closed -$1.76M – 2390
2022
Q1 		$1.76M Buy
+24,100
New +$1.62M 0.02% 1065
2020
Q2 		– Sell
-21,100
Closed -$1.18M – 1063
2020
Q1 		$1.18M Sell
21,100
-69,700
-77% -$4.26M 0.05% 227
2019
Q4 		$5.79M Sell
90,800
-32,600
-26% -$1.87M 0.11% 135
2019
Q3 		$6.21M Sell
123,400
-29,700
-19% -$1.4M 0.17% 93
2019
Q2 		$6.94M Buy
+153,100
New +$7.13M 0.2% 87

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's BMY Position: Q1 2026 in Review

Verition Fund Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 39,989 shares — an estimated $2.33M sold.

Verition Fund Management first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $15.9M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Verition Fund Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 39,989 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.33M.
  • Verition Fund Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Bristol-Myers Squibb position peaked at $15.9M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.